/IDTA

IDTA Stock - IDenta Corp.

Q: What is the analyst price target for IDTA?

Analyst price target information is not currently available for IDTA.

Q: What is IDTA's market cap?

Market capitalization information is not currently available for IDTA.

Healthcare|Medical - Diagnostics & Research|OTC

$0.17-11.17%

$0.02 (-11.17%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.19

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for IDTA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.68

52W High$0.75

52W Low$0.15

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$1.46M	$1.05M	$1.34M	$1.39M	$1.45M
Gross Profit	$756,460	$662,975	$983,393	$1.02M	$878,806
Gross Margin	52.0%	63.0%	73.5%	73.4%	60.6%
Operating Income	$280,901	$-1,499	$125,481	$214,152	$355,573
Net Income	$258,343	$14,644	$162,711	$69,183	$354,449
Net Margin	17.7%	1.4%	12.2%	5.0%	24.4%
EPS	$0.06	$0.00	$0.04	$0.02	$0.09

Company Overview

IDenta Corp. develops, manufactures, and supplies field detection and home diagnostics testing kits for narcotics and explosives, and forensic products in the homeland security and consumer markets worldwide. The company offers drug, explosives, and bullet-hole testing kits; FerroPrint testing products; blood detection kits; precursors of drugs test kits; and portable sniffers. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. IDenta Corp. was incorporated in 1997 and is headquartered in Jerusalem, Israel.

Visit Website

Frequently Asked Questions about IDTA

What is IDTA's current stock price?

IDenta Corp. (IDTA) is currently trading at $0.17 per share. The stock has moved -11.17% today.

What is the analyst price target for IDTA?

No analyst price targets are currently available for this stock.

What sector is IDenta Corp. in?

IDenta Corp. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.

What is IDTA's market cap?

IDenta Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does IDTA pay dividends?

No, IDenta Corp. does not currently pay a dividend to shareholders.